These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9469265)

  • 21. Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease.
    Costa A; Bini P; Hamze-Sinno M; Moglia A; Franciotta D; Sinforiani E; Ravaglia S; Bole-Feysot C; Hökfelt T; Déchelotte P; Fetissov SO
    J Neuroimmunol; 2011 Dec; 240-241():114-20. PubMed ID: 22078238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of Allergy on Immunoglobulins and Amyloid-β in the Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    Sarlus H; Eyjolfsdottir H; Eriksdotter M; Oprica M; Schultzberg M
    J Alzheimers Dis; 2015; 48(2):495-505. PubMed ID: 26402013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amino acid concentrations in cerebrospinal fluid in presenile and senile dementia of Alzheimer type and multi-infarct dementia.
    Degrell I; Hellsing K; Nagy E; Niklasson F
    Arch Gerontol Geriatr; 1989; 9(2):123-35. PubMed ID: 2686573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease.
    Liguori C; Romigi A; Nuccetelli M; Zannino S; Sancesario G; Martorana A; Albanese M; Mercuri NB; Izzi F; Bernardini S; Nitti A; Sancesario GM; Sica F; Marciani MG; Placidi F
    JAMA Neurol; 2014 Dec; 71(12):1498-505. PubMed ID: 25322206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum protease activity in chronic kidney disease patients: The GANI_MED renal cohort.
    Wolke C; Teumer A; Endlich K; Endlich N; Rettig R; Stracke S; Fiene B; Aymanns S; Felix SB; Hannemann A; Lendeckel U
    Exp Biol Med (Maywood); 2017 Mar; 242(5):554-563. PubMed ID: 28038565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
    Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cerebrospinal fluid amino acids in Alzheimer's disease].
    Gelot MA; Jeandel C; Belleville F; Nabet P; Penin F; Cuny G
    Ann Biol Clin (Paris); 1990; 48(3):182-4. PubMed ID: 2353750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased cerebrospinal fluid A beta38/A beta42 ratio in Alzheimer disease.
    Mehta PD; Pirttila T
    Neurodegener Dis; 2005; 2(5):242-5. PubMed ID: 16909004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
    Galimberti D; Schoonenboom N; Scheltens P; Fenoglio C; Bouwman F; Venturelli E; Guidi I; Blankenstein MA; Bresolin N; Scarpini E
    Arch Neurol; 2006 Apr; 63(4):538-43. PubMed ID: 16606766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer's disease.
    Mroczko B; Groblewska M; Zboch M; Muszyński P; Zajkowska A; Borawska R; Szmitkowski M; Kornhuber J; Lewczuk P
    J Alzheimers Dis; 2015; 43(3):1031-7. PubMed ID: 25159667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
    van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
    Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration of puromycin-sensitive alanyl aminopeptidase in Alzheimer disease brain.
    Minnasch P; Yamamoto Y; Ohkubo I; Nishi K
    Leg Med (Tokyo); 2003 Mar; 5 Suppl 1():S285-7. PubMed ID: 12935612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid amyloid beta(1-42) levels in the mild cognitive impairment stage of Alzheimer's disease.
    Maruyama M; Arai H; Sugita M; Tanji H; Higuchi M; Okamura N; Matsui T; Higuchi S; Matsushita S; Yoshida H; Sasaki H
    Exp Neurol; 2001 Dec; 172(2):433-6. PubMed ID: 11716567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression.
    Hesse R; Lausser L; Gummert P; Schmid F; Wahler A; Schnack C; Kroker KS; Otto M; Tumani H; Kestler HA; Rosenbrock H; von Arnim CA
    Alzheimers Res Ther; 2017 Mar; 9(1):17. PubMed ID: 28274265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
    Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
    JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative signature of cerebrospinal fluid from mild cognitive impairment and Alzheimer disease patients.
    Di Domenico F; Pupo G; Giraldo E; Badìa MC; Monllor P; Lloret A; Schininà ME; Giorgi A; Cini C; Tramutola A; Butterfield DA; Viña J; Perluigi M
    Free Radic Biol Med; 2016 Feb; 91():1-9. PubMed ID: 26675344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medial temporal lobe atrophy increases the specificity of cerebrospinal fluid biomarkers in Alzheimer disease with minor cerebrovascular changes.
    Zhang Y; Londos E; Minthon L; Wattmo C; Blennow K; Liu HJ; Bronge L; Aspelin P; Wahlund LO
    Acta Radiol; 2009 Jul; 50(6):674-81. PubMed ID: 19455444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.
    Haris M; Yadav SK; Rizwan A; Singh A; Cai K; Kaura D; Wang E; Davatzikos C; Trojanowski JQ; Melhem ER; Marincola FM; Borthakur A
    Neuroimage Clin; 2015; 7():598-604. PubMed ID: 25844314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.